Cell Viability Assays Market by Product, Cell Type, Application, End-User - Global Forecast 2025-2030- Product Image

Sale

Cell Viability Assays Market by Product, Cell Type, Application, End-User - Global Forecast 2025-2030

Report
188 Pages
October 2024
Region: Global
360iResearch™
ID: 6010770

UP TO €688EUR$697USD£570GBP OFF until Dec 31^st 2024

The Cell Viability Assays Market grew from USD 1.79 billion in 2023 to USD 1.99 billion in 2024. It is expected to continue growing at a CAGR of 11.38%, reaching USD 3.82 billion by 2030.

Cell viability assays are critical tools in biological research and pharmaceutical development, used to assess the health and metabolic activity of cells. These assays are necessary for determining the effects of various compounds on cell survival, aiding in drug discovery, toxicity testing, and optimizing cell culture conditions. They are widely applied in pharmaceutical and biotechnological industries, academic research, and clinical laboratories. End-use segments include pharmaceutical and biotechnology firms, academic and research institutions, hospitals, and diagnostic laboratories. The cell viability assays market is primarily driven by increasing research activities in drug discovery, growing prevalence of chronic diseases necessitating advanced treatment options, and the rising adoption of cell-based assays in clinical applications. Advancements in technology, such as high-throughput screening methods and automated systems, offer potential growth opportunities by increasing assay efficiency and reducing operational costs. Nonetheless, market expansion faces challenges like high costs of assay instruments and reagents, technical limitations in assay sensitivity and specificity, and ethical concerns related to cell and stem cell research. The rising demand for personalized medicine and increasing investment in research and development are fostering innovation in developing more sophisticated, accurate, and cost-effective assays. The market is also witnessing a shift towards more eco-friendly and compliant assay kits, driven by stringent regulatory frameworks. The best areas for innovation include the development of novel assay platforms that improve throughput and accuracy, and integration with digital tools for enhanced data analytics. Overall, the cell viability assays market is poised for substantial growth, albeit with challenges that necessitate strategic navigation. By prioritizing research in higher assay sensitivities and expanding applications in emerging fields like immuno-oncology and regenerative medicine, stakeholders can significantly leverage market potential and drive future innovations.

Understanding Market Dynamics in the Cell Viability Assays Market

The Cell Viability Assays Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing investments in cell-based research
- Rising number of clinical trials in economies
- Utilization of cell viability assays to screen water bodies
Market Restraints
- High cost of reagents and cell viability assays
Market Opportunities
- Development of highly sensitive and rapid protocol cell viability assays
- Adoption of cell viability in quality control operations
Market Challenges
- Technical limitations of cell viability assay

Exploring Porter’s Five Forces for the Cell Viability Assays Market

Porter’s Five Forces framework further strengthens the insights of the Cell Viability Assays Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cell Viability Assays Market

External macro-environmental factors deeply influence the performance of the Cell Viability Assays Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cell Viability Assays Market

The Cell Viability Assays Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cell Viability Assays Market

The Cell Viability Assays Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cell Viability Assays Market

The Cell Viability Assays Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Viability Assays Market, highlighting leading vendors and their innovative profiles. These include AAT Bioquest, Inc., Abcam PLC, Agilent Technologies, Inc., Akadeum Life Sciences, Assay Genie, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biotium, Inc., BMG LABTECH GmbH, Cell Biolabs, Inc., Creative Bioarray, Danaher Corporation, Elabscience Biotechnology Inc., Enzo Life Sciences, Inc., F. Hoffmann-La Roche AG, GE HealthCare Technologies, Inc., Hemogenix Inc., Illumina, Inc, Merck KGaA, Miltenyi Biotec B.V. & Co. KG, PerkinElmer, Inc., Promega Corporation, Qiagen N.V., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Viability Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Consumables
  - Assay Kits
    - Colorimetric assays
    - Dye exclusion assays
    - Fluorometric assays
    - Luminometric assays
  - Microplates
  - Reagents
- Instruments
  - Cell Imaging & Analysis System
  - Flow Cytometry
  - Microscopy
  - Spectrophotometer
Cell Type
- Animal Cells
- Human Cells
- Microbial Cells
Application
- Basic Research
- Clinical & Diagnostic Applications
- Drug Discovery & Development
- Stem Cell Research
End-User
- Academic & Research Institutes
- Hospital & Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing investments in cell-based research
5.1.1.2. Rising number of clinical trials in economies
5.1.1.3. Utilization of cell viability assays to screen water bodies
5.1.2. Restraints
5.1.2.1. High cost of reagents and cell viability assays
5.1.3. Opportunities
5.1.3.1. Development of highly sensitive and rapid protocol cell viability assays
5.1.3.2. Adoption of cell viability in quality control operations
5.1.4. Challenges
5.1.4.1. Technical limitations of cell viability assay
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Cell Viability Assays Market, by Product

6.1. Introduction
6.2. Consumables
6.2.1. Assay Kits
6.2.1.1. Colorimetric assays
6.2.1.2. Dye exclusion assays
6.2.1.3. Fluorometric assays
6.2.1.4. Luminometric assays
6.2.2. Microplates
6.2.3. Reagents
6.3. Instruments
6.3.1. Cell Imaging & Analysis System
6.3.2. Flow Cytometry
6.3.3. Microscopy
6.3.4. Spectrophotometer

7. Cell Viability Assays Market, by Cell Type

7.1. Introduction
7.2. Animal Cells
7.3. Human Cells
7.4. Microbial Cells

8. Cell Viability Assays Market, by Application

8.1. Introduction
8.2. Basic Research
8.3. Clinical & Diagnostic Applications
8.4. Drug Discovery & Development
8.5. Stem Cell Research

9. Cell Viability Assays Market, by End-User

9.1. Introduction
9.2. Academic & Research Institutes
9.3. Hospital & Diagnostic Laboratories
9.4. Pharmaceutical & Biotechnology Companies

10. Americas Cell Viability Assays Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Cell Viability Assays Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Cell Viability Assays Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation

LIST OF FIGURES

FIGURE 1. CELL VIABILITY ASSAYS MARKET RESEARCH PROCESS
FIGURE 2. CELL VIABILITY ASSAYS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. CELL VIABILITY ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. CELL VIABILITY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

TABLE 1. CELL VIABILITY ASSAYS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CELL VIABILITY ASSAYS MARKET DYNAMICS
TABLE 7. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY COLORIMETRIC ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY DYE EXCLUSION ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY FLUOROMETRIC ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY LUMINOMETRIC ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CELL IMAGING & ANALYSIS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY SPECTROPHOTOMETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY HUMAN CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY CLINICAL & DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CELL VIABILITY ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 61. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 62. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 63. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 68. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 70. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. AUSTRALIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 98. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 99. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 100. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 101. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. INDIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. INDIA CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 105. INDIA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 106. INDIA CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 107. INDIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 108. INDIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. INDIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. JAPAN CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. JAPAN CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 119. JAPAN CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 120. JAPAN CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 121. JAPAN CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 122. JAPAN CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. JAPAN CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. MALAYSIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. PHILIPPINES CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. SINGAPORE CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. SOUTH KOREA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. TAIWAN CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. THAILAND CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. THAILAND CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 161. THAILAND CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 162. THAILAND CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 163. THAILAND CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 164. THAILAND CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. THAILAND CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. VIETNAM CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 181. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 183. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 184. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 185. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 186. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. EGYPT CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. EGYPT CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 190. EGYPT CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 191. EGYPT CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 192. EGYPT CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 193. EGYPT CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. EGYPT CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. FINLAND CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. FINLAND CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 197. FINLAND CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 198. FINLAND CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 199. FINLAND CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 200. FINLAND CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. FINLAND CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 204. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 205. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 206. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 207. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 211. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 212. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 213. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 214. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. ISRAEL CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 223. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 225. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 226. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 227. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 228. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 244. NORWAY CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 245. NORWAY CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 246. NORWAY CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 247. NORWAY CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 248. NORWAY CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 249. NORWAY CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. NORWAY CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. POLAND CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. POLAND CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 253. POLAND CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 254. POLAND CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 255. POLAND CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 256. POLAND CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. POLAND CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 258. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 259. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 260. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 261. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 262. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 263. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 286. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 287. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 288. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 289. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 290. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 291. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. SWITZERLAND CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 307. TURKEY CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 308. TURKEY CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 309. TURKEY CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 310. TURKEY CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 311. TURKEY CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 312. TURKEY CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. TURKEY CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 324. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 326. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 328. CELL VIABILITY ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 329. CELL VIABILITY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Cell Viability Assays market, which are profiled in this report, include:

AAT Bioquest, Inc.
Abcam PLC
Agilent Technologies, Inc.
Akadeum Life Sciences
Assay Genie
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
Biotium, Inc.
BMG LABTECH GmbH
Cell Biolabs, Inc.
Creative Bioarray
Danaher Corporation
Elabscience Biotechnology Inc.
Enzo Life Sciences, Inc.
F. Hoffmann-La Roche AG
GE HealthCare Technologies, Inc.
Hemogenix Inc.
Illumina, Inc
Merck KGaA
Miltenyi Biotec B.V. & Co. KG
PerkinElmer, Inc.
Promega Corporation
Qiagen N.V.
Thermo Fisher Scientific, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	188
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.99 Billion
Forecasted Market Value ( USD ) by 2030	$ 3.82 Billion
Compound Annual Growth Rate	11.3%
Regions Covered	Global
No. of Companies Mentioned	26

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3499EUR$3,545USD£2,902GBP €3888EUR$3,939USD£3,224GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6191EUR$6,272USD£5,134GBP €6879EUR$6,969USD£5,704GBP

Understanding Market Dynamics in the Cell Viability Assays Market

Exploring Porter’s Five Forces for the Cell Viability Assays Market

Applying PESTLE Analysis to the Cell Viability Assays Market

Analyzing Market Share in the Cell Viability Assays Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cell Viability Assays Market

Strategic Recommendations for Success in the Cell Viability Assays Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Cell Viability Assays - Global Strategic Business Report

Cell Viability Assays - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Cell Viability Assays Global Market Report 2024

Cell Viability Assays Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F

2024 Global Forecast for Cell Viability Assays Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

About the Cell Viability Assay Market